Quick filters:
Open Data
Open Code
Pre-registered
Funding Declared
COI Declared
Open Access
Clear Filters
Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in pat…
Khushalani NI; Ott PA; Ferris RL; Cascone T; Schadendorf D; Le DT; Sharma MR; Barlesi F; Sharfman W; Luke JJ; Melero I; Lathers D; Neely J; Suryawanshi S; Sanyal A; Holloway JL; Suryawanshi R; Ely S; Segal NH.
J Immunother Cancer
(Unknown)
Published: 2024
Hybrid epithelial-mesenchymal status of lung cancer dictates metastatic success through differential interaction with N…
Parodi M; Centonze G; Murianni F; Orecchia P; Andriani F; Roato I; Gardelli C; Balsamo M; Moro M; Taiè G; Pastorino U; Petretto A; Lavarello C; Milione M; Sozzi G; Roz L; Vitale M; Bertolini G.
J Immunother Cancer
(Unknown)
Published: 2024
Mucosal tumor vaccination delivering endogenous tumor antigens protects against pulmonary breast cancer metastases.
Oltmanns F; Vieira Antão A; Irrgang P; Viherlehto V; Jörg L; Schmidt A; Wagner JT; Rückert M; Flohr AS; Geppert CI; Frey B; Bayer W; Gravekamp C; Tenbusch M; Gaipl U; Lapuente D.
J Immunother Cancer
(Unknown)
Published: 2024
Fluctuations in serum adrenocorticotropic hormone concentration may predict the onset of immune checkpoint inhibitor-re…
Bando H; Yamamoto M; Urai S; Motomura Y; Sasaki Y; Ohmachi Y; Kobatake M; Tsujimoto Y; Oi-Yo Y; Suzuki M; Yamamoto N; Takahashi M; Fukuoka H; Iguchi G; Ogawa W.
J Immunother Cancer
(Unknown)
Published: 2024
First-line treatment with camrelizumab plus famitinib in advanced or metastatic NSCLC patients with PD-L1 TPS ≥1%: resu…
Ren S; Wang X; Han BH; Pan Y; Zhao J; Cheng Y; Hu S; Liu T; Li Y; Cheng Y; Feng J; Yi S; Gu S; Gao S; Luo Y; Liu Y; Liu C; Duan H; Wang S; Yang X; Fan J; Zhou C.
J Immunother Cancer
(Unknown)
Published: 2024
Machine learning analysis of pathological images to predict 1-year progression-free survival of immunotherapy in patien…
Shibaki R; Fujimoto D; Nozawa T; Sano A; Kitamura Y; Fukuoka J; Sato Y; Kijima T; Matsumoto H; Yokoyama T; Miura S; Hata A; Tamiya M; Taniguchi Y; Sugisaka J; Furuya N; Tanaka H; Yamamoto N; Koh Y; Akamatsu H.
J Immunother Cancer
(Unknown)
Published: 2024
Inflamed immune phenotype predicts favorable clinical outcomes of immune checkpoint inhibitor therapy across multiple c…
Shen J; Choi YL; Lee T; Kim H; Chae YK; Dulken BW; Bogdan S; Huang M; Fisher GA; Park S; Lee SH; Hwang JE; Chung JH; Kim L; Song H; Pereira S; Shin S; Lim Y; Ahn CH; Kim S; Oum C; Kim S; Park G; Song S; Jung W; Kim S; Bang YJ; Mok TSK; Ali SM; Ock CY.
J Immunother Cancer
(Unknown)
Published: 2024
Four-year clinical update and treatment switching-adjusted outcomes with first-line nivolumab plus ipilimumab with chem…
Carbone DP; Ciuleanu TE; Schenker M; Cobo M; Bordenave S; Juan-Vidal O; Menezes J; Reinmuth N; Richardet E; Cheng Y; Mizutani H; Felip E; Zurawski B; Alexandru A; Paz-Ares L; Lu S; John T; Zhang X; Mahmood J; Hu N; De T; Santi I; Penrod JR; Yuan Y; Lee A; Reck M.
J Immunother Cancer
(Unknown)
Published: 2024
Multiomic molecular characterization of the response to combination immunotherapy in MSS/pMMR metastatic colorectal can…
Takei S; Tanaka Y; Lin YT; Koyama S; Fukuoka S; Hara H; Nakamura Y; Kuboki Y; Kotani D; Kojima T; Bando H; Mishima S; Ueno T; Kojima S; Wakabayashi M; Sakamoto N; Kojima M; Kuwata T; Yoshino T; Nishikawa H; Mano H; Endo I; Shitara K; Kawazoe A.
J Immunother Cancer
(Unknown)
Published: 2024
Nivolumab monotherapy or combination with ipilimumab with or without cobimetinib in previously treated patients with pa…
Callahan M; Amin A; Kaye FJ; Morse MA; Taylor MH; Peltola KJ; Sharma P; O'Reilly EM; Meadows Shropshire S; O'Brien S; Tschaika M; Le DT.
J Immunother Cancer
(Unknown)
Published: 2024
First exploration of the on-treatment changes in tumor and organ uptake of a radiolabeled anti PD-L1 antibody during ch…
Pouw JEE; Hashemi SMS; Huisman MC; Wijngaarden JE; Slebe M; Oprea-Lager DE; Zwezerijnen GJC; Vugts D; Ulas EB; de Gruijl TD; Radonic T; Senan S; Menke-van der Houven van Oordt CW; Bahce I.
J Immunother Cancer
(Unknown)
Published: 2024